Lime Chemicals Limited (BOM:507759)
India · Delayed Price · Currency is INR 13.55
-0.45 (-3.21%)
At close: Aug 21, 2026
Lime Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 114.94 | 71.17 | 96.67 | 104.55 | 154.78 | 140.56 |
Other Revenue | -1.81 | - | - | - | - | - |
| 113.13 | 71.17 | 96.67 | 104.55 | 154.78 | 140.56 | |
Revenue Growth | 33.41% | -26.38% | -7.54% | -32.45% | 10.11% | -37.01% |
Cost of Revenue | 87.19 | 54.02 | 64.21 | 76.49 | 112.05 | 91.07 |
Gross Profit | 25.95 | 17.15 | 32.46 | 28.06 | 42.73 | 49.5 |
Selling, General & Admin | 7.5 | 7.25 | 10.21 | 9.91 | 10.11 | 8.02 |
Other Operating Expenses | 17.4 | 10.43 | 18.05 | 24.11 | 30.32 | 47.62 |
Operating Expenses | 25.73 | 18.52 | 29.02 | 34.94 | 42.67 | 58.2 |
Operating Income | 0.22 | -1.37 | 3.44 | -6.88 | 0.06 | -8.7 |
Interest Expense | -0.3 | -0.31 | -1.52 | -0.31 | -0.78 | -2.04 |
Interest & Investment Income | - | - | 0.52 | 0.54 | 0.84 | 1.02 |
Currency Exchange Gain (Loss) | - | - | -0.01 | -0.01 | 0 | - |
Other Non Operating Income (Expenses) | 0 | - | -0 | 5.07 | 0 | 0.13 |
EBT Excluding Unusual Items | -0.07 | -1.68 | 2.43 | -1.59 | 0.13 | -9.59 |
Gain (Loss) on Sale of Investments | - | - | -0.03 | 0.07 | -0.2 | -0 |
Gain (Loss) on Sale of Assets | - | - | - | -0.11 | - | -2.61 |
Asset Writedown | - | - | - | - | - | -0.47 |
Other Unusual Items | -0.04 | -0.04 | - | - | 30.87 | 110.63 |
Pretax Income | -0.12 | -1.72 | 2.39 | -1.63 | 30.8 | 97.96 |
Income Tax Expense | - | - | 0.18 | 3.29 | 3.23 | - |
Net Income | -0.12 | -1.72 | 2.21 | -4.92 | 27.57 | 97.96 |
Net Income to Common | -0.12 | -1.72 | 2.21 | -4.92 | 27.57 | 97.96 |
Net Income Growth | - | - | - | - | -71.86% | 7140.13% |
Shares Outstanding (Basic) | 7 | 8 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 7 | 8 | 7 | 7 | 7 | 7 |
Shares Change | -4.09% | 20.40% | - | - | - | - |
EPS (Basic) | -0.02 | -0.22 | 0.34 | -0.76 | 4.24 | 15.06 |
EPS (Diluted) | -0.02 | -0.22 | 0.34 | -0.76 | 4.24 | 15.06 |
EPS Growth | - | - | - | - | -71.86% | 7140.15% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 5.17 | -3.2 | 4.98 | -26.34 | -73.3 |
Free Cash Flow Per Share | - | 0.66 | -0.49 | 0.77 | -4.05 | -11.27 |
Gross Margin | 22.94% | 24.09% | 33.58% | 26.84% | 27.61% | 35.21% |
Operating Margin | 0.20% | -1.92% | 3.56% | -6.58% | 0.04% | -6.19% |
Profit Margin | -0.10% | -2.42% | 2.29% | -4.70% | 17.81% | 69.69% |
Free Cash Flow Margin | - | 7.27% | -3.31% | 4.76% | -17.02% | -52.14% |
EBITDA | 1.09 | -0.53 | 4.2 | -5.96 | 2.3 | -6.84 |
EBITDA Margin | 0.96% | -0.74% | 4.35% | -5.70% | 1.48% | -4.87% |
D&A For EBITDA | 0.86 | 0.84 | 0.76 | 0.92 | 2.24 | 1.86 |
EBIT | 0.22 | -1.37 | 3.44 | -6.88 | 0.06 | -8.7 |
EBIT Margin | 0.20% | -1.92% | 3.56% | -6.58% | 0.04% | -6.19% |
Effective Tax Rate | - | - | 7.60% | - | 10.49% | - |
Revenue as Reported | 117.16 | 75.19 | 102.76 | 108.51 | 156.01 | 142.68 |
Advertising Expenses | - | - | 0.4 | 0.65 | 0.09 | 0.07 |